Perceptive Advisors LLC Geron Corp Put Options Transaction History

Perceptive Advisors LLC

  • $3.46 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.98 - $1.85 $1.91 Million - $3.61 Million
-1,950,000 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$1.76 - $6.38 $704,000 - $2.55 Million
-400,000 Reduced 17.02%
1,950,000 $3.68 Million
Q2 2018

Aug 14, 2018
BUY
$3.29 - $4.82 $5.76 Million - $8.44 Million
1,750,000 Added 291.67%
2,350,000 $2.89 Million
Q1 2018

May 15, 2018
BUY
$1.81 - $5.98 $1.09 Million - $3.59 Million
600,000 New
600,000 $600,000

Others Institutions Holding GERN

# of Institutions
259
Shares Held
450M
Call Options Held
1.91M
Put Options Held
897K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email